Creative Biolabs-Immuno-oncology

Anti-CCL2 (clone 2E.4I.1G) SynExpress C-Cy3-I4-E Modified CD8+ T cells (CAT#: ITS-1224-CR272)

DatasheetDatasheet
Description
This product utilizes Modified CD8+ T cells that have been engineered with our proprietary GeneCircuit technology to specifically target CCL2 (clone 2E.4I.1G). We employs the pAS (CMV-Cy3-IL-4-EcoRI) vector components and the SynExpress system of the lncRNA Base Editing/Positive feedback for a robust and sustained response against cancers.
Host
Human
Target
CCL2
Clone
2E.4I.1G
Species Reactivity
Human
Cell Source
Modified CD8+ T cells
Sensor Gene
Cy3
Promoter
CMV
Effector Gene
IL-4
Insertion Sites
EcoRI
Gene Modification
Base Editing
Modification Domain
lncRNA
Carrier Type
pAS
Transformation Accuracy
0.97
Cell Culture
3D Culture
Related Products

For Research Use Only | Not For Clinical Use

Online Inquiry
Copyright © 2026 Creative Biolabs. All Rights Reserved.
ISO 9001 Certified - Creative Biolabs Quality Management System.
Close
Thanksgiving
Thanksgiving